206 related articles for article (PubMed ID: 20012396)
1. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Niens M; Kulik J; Dilorenzo TP
Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
[TBL] [Abstract][Full Text] [Related]
2. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
3. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
DiLorenzo TP; Serreze DV
Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes.
Park Y
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S19-25. PubMed ID: 15563974
[TBL] [Abstract][Full Text] [Related]
5. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
6. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
[TBL] [Abstract][Full Text] [Related]
7. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
8. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cells in type 1 diabetes.
Tsai S; Shameli A; Santamaria P
Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
[TBL] [Abstract][Full Text] [Related]
10. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
11. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
Reich EP; Sherwin RS; Kanagawa O; Janeway CA
Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
[TBL] [Abstract][Full Text] [Related]
12. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
[TBL] [Abstract][Full Text] [Related]
13. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
14. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
15. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
16. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes.
Rajagopalan G; Mangalam AK; Sen MM; Kudva YC; David CS
Autoimmunity; 2007 Nov; 40(7):489-96. PubMed ID: 17966038
[TBL] [Abstract][Full Text] [Related]
17. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
Götz J; Eibel H; Köhler G
Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
[TBL] [Abstract][Full Text] [Related]
18. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.
Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E
Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066
[TBL] [Abstract][Full Text] [Related]
19. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
20. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
